Rodney Young
2021 - RAPT Therapeutics
In 2021, Rodney Young earned a total compensation of $1.4M as Chief Financial Officer at RAPT Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $157,657 |
|---|---|
| Option Awards | $818,464 |
| Salary | $404,250 |
| Total | $1,380,371 |
Young received $818.5K in option awards, accounting for 59% of the total pay in 2021.
Young also received $157.7K in non-equity incentive plan and $404.3K in salary.
Rankings
In 2021, Rodney Young's compensation ranked 7,599th out of 12,415 executives tracked by ExecPay. In other words, Young earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,599 out of 12,415 | 39th |
Division Manufacturing | 3,347 out of 5,505 | 39th |
Major group Chemicals And Allied Products | 1,483 out of 2,375 | 38th |
Industry group Drugs | 1,319 out of 2,096 | 37th |
Industry Pharmaceutical Preparations | 974 out of 1,546 | 37th |
Source: SEC filing on April 11, 2022.
Young's colleagues
We found two more compensation records of executives who worked with Rodney Young at RAPT Therapeutics in 2021.